openPR Logo
Press release

Ulcerative Colitis Market Set to Surpass $10.8 Billion by 2030: Unveiling a Promising Future for Patient Care

06-12-2023 06:41 PM CET | Health & Medicine

Press release from: Allied Market Research

Ulcerative Colitis Market

Ulcerative Colitis Market

The ulcerative colitis market, a significant healthcare sector, exhibited promising growth in recent years. In 2020, it was valued at $6.2 billion, reflecting the escalating demand for advanced treatments and therapeutic options. As we look towards the future, the market is poised to witness remarkable expansion, projected to reach a staggering value of $10.8 billion by 2030. This projection suggests a substantial compound annual growth rate (CAGR) of 5.7% from 2021 to 2030, indicating the increasing prevalence of the disease and the need for effective interventions.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž: https://www.alliedmarketresearch.com/request-sample/3965

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

Merck & Co. Inc., GLAXOSIMITHKLINE PLC, AJINOMOTO CO. INC., ELI-LILLY, SANOFI S.A, INDEX PHARMACEUTICALS HOLDINGS AB, ABBOTT LABORATORIES, Pfizer Inc., JOHNSON & JOHNSON, ASTRAZENECA PLC

๐“๐ก๐ž ๐ฎ๐ฅ๐œ๐ž๐ซ๐š๐ญ๐ข๐ฏ๐ž ๐œ๐จ๐ฅ๐ข๐ญ๐ข๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐๐ข๐ฏ๐ž๐ซ๐ฌ๐ž ๐š๐ง๐ ๐ž๐ง๐œ๐จ๐ฆ๐ฉ๐š๐ฌ๐ฌ๐ž๐ฌ ๐ฏ๐š๐ซ๐ข๐จ๐ฎ๐ฌ ๐š๐ฌ๐ฉ๐ž๐œ๐ญ๐ฌ ๐จ๐Ÿ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ญ๐ฒ๐ฉ๐ž๐ฌ, ๐ฆ๐จ๐ฅ๐ž๐œ๐ฎ๐ฅ๐ž ๐ญ๐ฒ๐ฉ๐ž๐ฌ, ๐š๐ง๐ ๐ซ๐จ๐ฎ๐ญ๐ž๐ฌ ๐จ๐Ÿ ๐š๐๐ฆ๐ข๐ง๐ข๐ฌ๐ญ๐ซ๐š๐ญ๐ข๐จ๐ง. ๐‡๐ž๐ซ๐ž ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐ก๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐Ÿ ๐ž๐š๐œ๐ก ๐œ๐š๐ญ๐ž๐ ๐จ๐ซ๐ฒ:

Disease Types:
1. Mild UC: This category refers to ulcerative colitis cases characterized by milder symptoms and limited inflammation in the colon and . Patients with mild UC often experience less frequent and less severe flare-ups, which can be managed with a combination of lifestyle modifications, dietary changes, and medications.
2. Moderate UC: Moderate UC represents a stage of the disease where patients experience more pronounced symptoms and inflammation in the colon and. It may involve more frequent flare-ups, leading to disruptions in daily life. Treatment options for moderate UC typically include medications such as aminosalicylates and immunosuppressants to control inflammation and manage symptoms.
3. Severe UC: Severe UC refers to cases with severe inflammation and symptoms that significantly impact a patient's quality of life. Patients with severe UC often experience frequent and intense flare-ups, leading to complications and potential hospitalizations. Treatment for severe UC may involve stronger immunosuppressive medications, corticosteroids, or biologic therapies to induce and maintain remission.

Molecule Types:

1. Biologics: Biologics are a class of medications derived from living organisms or their components. In the context of ulcerative colitis, biologics play a crucial role in targeting specific molecules involved in the inflammatory process. Biologic therapies such as anti-TNF agents (e.g., infliximab, adalimumab), anti-integrin agents (e.g., vedolizumab), and interleukin inhibitors (e.g., ustekinumab) have shown efficacy in managing moderate to severe UC by reducing inflammation and promoting remission.

2. Small Molecules: Small molecules are conventional pharmaceutical compounds typically synthesized chemically. In the treatment of ulcerative colitis, small molecules primarily include traditional medications like aminosalicylates, corticosteroids, and immunosuppressants. These drugs work through different mechanisms to reduce inflammation, suppress the immune response, and alleviate symptoms.

Routes of Administration:

1. Oral: Oral administration involves delivering medications in the form of tablets, capsules, or liquids that are taken by mouth. Several medications for ulcerative colitis can be administered orally, including aminosalicylates, corticosteroids, and some immunosuppressants. Oral medications offer convenience and ease of use for patients who can self-administer their treatment at home.

2. Injectables: Injectable medications are administered through subcutaneous or intravenous routes. In the case of ulcerative colitis, biologic therapies are often administered via injections. Subcutaneous injections can be self-administered by patients, whereas intravenous infusions are typically administered in healthcare settings. Injectable medications allow for targeted delivery and may provide more rapid and potent effects compared to oral medications.

๐๐ซ๐จ๐œ๐ฎ๐ซ๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (225 ๐๐š๐ ๐ž๐ฌ ๐๐ƒ๐… ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐‚๐ก๐š๐ซ๐ญ๐ฌ, ๐“๐š๐›๐ฅ๐ž๐ฌ, ๐š๐ง๐ ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ): https://www.alliedmarketresearch.com/ulcerative-colitis-market/purchase-options

๐๐‘๐Ž๐–๐’๐„ ๐“๐‘๐„๐๐ƒ๐ˆ๐๐† ๐‘๐„๐๐Ž๐‘๐“๐’-
DNA Diagnostics Market - https://www.alliedmarketresearch.com/dna-diagnostics-market

Biomaterials Market - https://www.alliedmarketresearch.com/biomaterials-market

Asthma and COPD Drugs Market - https://www.alliedmarketresearch.com/asthma-COPD-drug-market

Atrial Fibrillation Market - https://www.alliedmarketresearch.com/atrial-fibrillation-market

Remote Patient Monitoring Market -
https://www.alliedmarketresearch.com/remote-patient-monitoring-market

Vaccines Market - https://www.alliedmarketresearch.com/vaccines-market

Dental Consumables Market - https://www.alliedmarketresearch.com/dental-consumables-market

Sports Medicine Market - https://www.alliedmarketresearch.com/Sports-Medicine-market

Breast Biopsy Market - https://www.alliedmarketresearch.com/Breast-Biopsy-market

External Defibrillators Market - https://www.alliedmarketresearch.com/external-defibrillators-market

Blood Market - https://www.alliedmarketresearch.com/blood-market

Insomnia Market - https://www.alliedmarketresearch.com/insomnia-market

Indian Dental Consumables Market -
https://www.alliedmarketresearch.com/indian-dental-consumables-market

Intraoral Scanners Market - https://www.alliedmarketresearch.com/intraoral-scanners-market

UK IVD Market - https://www.alliedmarketresearch.com/uk-ivd-market

Ulcerative Colitis Market- https://www.alliedmarketresearch.com/ulcerative-colitis-market

Lateral Flow Assays Market https://www.alliedmarketresearch.com/lateral-flow-assay-market

Safety Needles Market https://www.alliedmarketresearch.com/safety-needles-market

Enteral Nutrition Market https://www.alliedmarketresearch.com/enteral-nutrition-market

pharmacogenomics market https://www.alliedmarketresearch.com/pharmacogenomics-market

Laboratory Equipment and Disposables Market https://www.alliedmarketresearch.com/laboratory-equipment-and-disposables-market

Cell Therapy Market
https://www.alliedmarketresearch.com/cell-therapy-market

Irritable Bowel Syndrome Treatment Market https://www.alliedmarketresearch.com/irritable-bowel-syndrome-treatment-market-A05948

Disposable Syringes Market https://www.alliedmarketresearch.com/disposable-syringes-market-A06120

Pharmaceutical Drug Delivery Market https://www.alliedmarketresearch.com/pharmaceutical-drug-delivery-market-A06102

VR In Healthcare Market https://www.alliedmarketresearch.com/vr-in-healthcare-market-A06193

Inhaled Nitric Oxide Market https://www.alliedmarketresearch.com/inhaled-nitric-oxide-market

Oral Antibiotics Market https://www.alliedmarketresearch.com/oral-antibiotics-market-A06540

Surrogacy Market https://www.alliedmarketresearch.com/surrogacy-market-A06580

Neurorehabilitation Market https://www.alliedmarketresearch.com/neurorehabilitation-market-A10461

European Antibiotics Market https://www.alliedmarketresearch.com/european-antibiotics-market-A10311

Cardiac Mapping Market https://www.alliedmarketresearch.com/cardiac-mapping-market-A10920

Cellulite Treatment Market https://www.alliedmarketresearch.com/cellulite-treatment-market-A10923

Blepharoplasty Market https://www.alliedmarketresearch.com/blepharoplasty-market-A10890

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Market Set to Surpass $10.8 Billion by 2030: Unveiling a Promising Future for Patient Care here

News-ID: 3085748 • Views: โ€ฆ

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collectโ€ฆ
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growthโ€ฆ
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil โ€ฆ
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strictโ€ฆ
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of โ€ฆ
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise inโ€ฆ

All 5 Releases


More Releases for Ulcerative

Ulcerative Colitis Pipeline Insights Report | DelveInsight
DelveInsight's, "Ulcerative Colitis Pipeline Insight" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ulcerative Colitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stayโ€ฆ
Novel Therapies for Ulcerative Colitis Patients
"The Business Research Company recently released a comprehensive report on the Global Ulcerative Colitis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The ulcerative colitis market sizeโ€ฆ
Ulcerative Colitis Market - Breaking Barriers, Transforming Digestive Health: Ul โ€ฆ
Newark, New Castle, USA: The "Ulcerative Colitis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ulcerative Colitis Market: https://www.growthplusreports.com/report/ulcerative-colitis-market/8815 This latest report researches the industry structure, sales, revenue,โ€ฆ
Ulcerative Colitis Market - Breaking Barriers, Empowering Resilience: Transformi โ€ฆ
Newark, New Castle, USA - new report, titled Ulcerative Colitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ulcerative Colitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ulcerative Colitis market. The report offers an overview of the market, whichโ€ฆ
Ulcerative Colitis - Drug Pipeline Landscape, 2023
Global Ulcerative Colitis Market report from Global Insight Services is the single authoritative source of intelligence on ulcerative colitis market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,โ€ฆ
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplainedโ€ฆ